HENRY SCHMITZ
Impact in
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
-
- Medicinal plant effects and applications
Papers in
-
- Microbial Natural Products and Biosynthesis 5
-
- Chemical Reactions and Isotopes 5
- Co-authors
- C. A. Claridge (5 shared papers)Irving R. Hooper (7 shared papers)Bert Behnke (1 shared paper)Katrin Giller (1 shared paper)William T. Bradner (4 shared papers)Dennis Lee Johnson (2 shared papers)R. U. Lemieux (1 shared paper)JOSEPH LEIN (4 shared papers)
- Journals
- The Journal of Antibiotics (6 papers)Archiv der Pharmazie (3 papers)Journal of the American Chemical Society (2 papers)Applied and Environmental Microbiology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- GermanyUnited KingdomNew Zealand
In The Last Decade
HENRY SCHMITZ
29 papers receiving 234 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 101
- Complementary and alternative medicine 41
- Molecular Medicine 20
- Microbiology 3
- Biochemistry 21
Countries citing papers authored by HENRY SCHMITZ
This map shows the geographic impact of HENRY SCHMITZ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HENRY SCHMITZ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HENRY SCHMITZ more than expected).
Fields of papers citing papers by HENRY SCHMITZ
This network shows the impact of papers produced by HENRY SCHMITZ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HENRY SCHMITZ. The network helps show where HENRY SCHMITZ may publish in the future.
Co-authors
The 21 scholars most cited alongside HENRY SCHMITZ, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [Anti-inflammatory effect of Urtica dioica folia extract in comparison to caffeic malic acid]. | 1996 | 57 |
| 2 | 1958 | 41 | |
| 3 | 1958 | 22 | |
| 4 | 1982 | 22 | |
| 5 | 1958 | 20 | |
| 6 | 1976 | 19 | |
| 7 | 1978 | 17 | |
| 8 | Studies on sarkomycin. | 1955 | 13 |
| 9 | 1979 | 13 | |
| 10 | 1979 | 11 | |
| 11 | Actinogan: a new antitumor agent obtained from Streptomyces. I. Chemical and biological properties. | 1962 | 8 |
| 12 | Semisynthetic coumermycins. II. Preparation and properties of 3-(substituted benzamido)-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl)noviosyloxy] coumarins. | 1968 | 8 |
| 13 | Miamycin, a new antibiotic. | 1957 | 7 |
| 14 | 1968 | 7 | |
| 15 | 1968 | 6 | |
| 16 | NSC A-649, an antitumor antibiotic. | 1960 | 5 |
| 17 | 1977 | 5 | |
| 18 | 1978 | 5 | |
| 19 | Mycorhodin, a new antibiotic. | 1959 | 4 |
| 20 | Mycolutein, a new antifungal antibiotic. | 1955 | 3 |
About HENRY SCHMITZ
HENRY SCHMITZ is a scholar working on Pharmacology, Pharmaceutical Science, Cancer Research, Organic Chemistry and Physical and Theoretical Chemistry, having authored 30 papers that have together received 312 indexed citations. Recurring topics across this work include Chemical Reactions and Isotopes (5 papers), Microbial Natural Products and Biosynthesis (5 papers), Synthesis and Biological Activity (5 papers), Cancer therapeutics and mechanisms (5 papers), Chemical synthesis and alkaloids (4 papers), Plant chemical constituents analysis (3 papers), Chemical Reactions and Mechanisms (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). The work is most often cited by research in Pharmacology (101 citations), Complementary and alternative medicine (41 citations), Molecular Medicine (20 citations), Microbiology (3 citations) and Biochemistry (21 citations). HENRY SCHMITZ has collaborated with scholars based in Germany, United Kingdom and New Zealand. Frequent co-authors include C. A. Claridge, Irving R. Hooper, Bert Behnke, Katrin Giller, William T. Bradner, Dennis Lee Johnson, R. U. Lemieux, JOSEPH LEIN, Walter G. Schunack and Bernard Heinemann. Their work appears in journals such as The Journal of Antibiotics, Archiv der Pharmazie, Journal of the American Chemical Society, Applied and Environmental Microbiology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.